TG Therapeutics reports triple therapy data from Phase I/II study of ublitux
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Soleno Therapeutics expects topline data for Phase III DESTINY PWS study in 1H20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam initiates Phase 3 study of lumasiran, reports "positive" Phase 2 data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Crispr Therapeutics expects data from Phase 1/2 study of CTX001 in late 2019
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Immutep reports efficacy data for TACTI-mel Phase 1 clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Relmada Therapeutics repors data from REL-1017-202 Phase 2 clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Summit Therapeutics reports data from Phase 2 trial of ridinilazole
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amicus Therapeutics (FOLD) Presents Additional Data from Phase 1/2 Study of AT-GAA - Slideshow
Amicus Therapeutics (FOLD) Presents Additional Data from Phase 1/2 Study of AT-GAA - Slideshow.....»»
Aravive reports data from Phase 1b/2 study of AVB-500 in ovarian cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ovid Therapeutics expects initial data from Phase 2 ARCADE study in Q1
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
vTv Therapeutics presents additional data from Phase 2 Simplici-T1 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xynomic reports interim data from Phase 1b study of abexinostat w/ Keytruda
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Completed enrollment of the dose expansion cohort in the Phase 1b/2 CLASSICAL-Lung study in non-small cell lung cancer; primary completion expected in the second half of 2019 Presented interim data from CLASSICAL-Lung study.....»»
Deciphera reports updated data from Phase 1 ripretinib study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aptevo Therapeutics expects preliminary data from APVO436 Phase 1/1b study in Q4
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hemispherx reports "positive" data in Phase 1 study using Ampligen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Evofem reports additional data from Phase 3 "AMPOWER" study of Amphora
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer’s Duchenne Muscular Dystrophy Pain Could Make Sarepta the DMD King
Pfizer released initial clinical data from its Phase 1b gene therapy study for Duchenne muscular dystrophy. While these results did not necessarily live up to expectations, there is a winner in this......»»
Sarepta surges after Pfizer gene therapy data raises safety concerns
Shares of Sarepta Therapeutics Inc surged 15% on Friday after some safety concerns were raised in a small, early-stage study of a competing gene therapy for a rare muscle-wasting disorder from Pfizer Inc ......»»
Pfizer presents initial clinical data on Phase 1b DMD gene therapy study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Entera Bio Reports First Quarter 2019 Financial Results and Operating Update
Phase 2b Study for oral PTH in osteoporosis to begin by mid-year 2019 Completed Part 2 of a Phase 2 PK/PD study in hypoparathyroidism patients. Data processing and statistical analysi.....»»